ストックスクリーナーアプリを入手
68.32
0.37%
0.2514
前日終値:
$68.07
開ける：
$67.925
24時間の取引高:
8,390
Relative Volume:
0.93
時価総額：
$281.93M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.70%
1か月 パフォーマンス:
+6.75%
6か月 パフォーマンス:
+0.31%
1年 パフォーマンス:
-4.60%
1日の値動き範囲:
$67.92
$68.50
1週間の範囲:
$67.05
$68.50
52週間の値動き範囲:
$54.52
$72.84
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
PBE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
68.38 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
313.01 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
636.08 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
639.16 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
245.08 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
563.93 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf (PBE) 最新ニュース
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Short Interest Update - Defense World
Farther Finance Advisors LLC Acquires 6,201 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World
Citadel Advisors LLC Grows Stake in Innovator U.S. Equity Ultra Buffer ETF – January (BATS:UJAN) - Defense World
8,551 Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Acquired by Citadel Advisors LLC - Defense World
Bank of America Corp DE Has $4.59 Million Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Stake Lessened by Cetera Investment Advisers - Defense World
Stifel Financial Corp Acquires 16,892 Shares of RiverNorth Managed Duration Municipal Income Fund II, Inc. (NYSEARCA:RMMZ) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Stifel Financial Corp Sells 600 Shares of SRH Total Return Fund, Inc. (NYSE:STEW) - Defense World
Stifel Financial Corp Sells 1,457 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Stifel Financial Corp Grows Stock Holdings in Schwab U.S. REIT ETF (NYSEARCA:SCHH) - Defense World
Susquehanna International Group LLP Makes New Investment in VictoryShares Core Intermediate Bond ETF (NASDAQ:UITB) - Defense World
Stifel Financial Corp Acquires 5,291 Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Barclays PLC Buys 10,174 Shares of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – January (NYSEARCA:XJAN) - Defense World
16,974 Shares in VNET Group, Inc. (NASDAQ:VNET) Bought by Tower Research Capital LLC TRC - Defense World
Tower Research Capital LLC TRC Lowers Position in The Marcus Co. (NYSE:MCS) - Defense World
Hsbc Holdings PLC Has $232,000 Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) - Defense World
Hsbc Holdings PLC Takes Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - Defense World
Tower Research Capital LLC TRC Has $71,000 Holdings in CTO Realty Growth, Inc. (NYSE:CTO) - Defense World
Dimensional Fund Advisors LP Raises Stake in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Dimensional Fund Advisors LP Raises Holdings in Blue Foundry Bancorp (NASDAQ:BLFY) - Defense World
Klaviyo, Inc. (NYSE:KVYO) Shares Bought by Tower Research Capital LLC TRC - Defense World
LENZ Therapeutics’ (LENZ) “Buy” Rating Reiterated at HC Wainwright - Defense World
Gladstone Commercial Co. (NASDAQ:GOOD) Stake Raised by Dimensional Fund Advisors LP - Defense World
Hsbc Holdings PLC Makes New Investment in Customers Bancorp, Inc. (NYSE:CUBI) - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for Russel Metals (TSE:RUS) Stock Price - Defense World
(PBE) Investment Analysis - news.stocktradersdaily.com
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Diamond Hill Investment Group, Inc. (NASDAQ:DHIL) Shares Sold by First Trust Advisors LP - Defense World
Marshall Wace LLP Purchases Shares of 38,500 908 Devices Inc. (NASDAQ:MASS) - Defense World
Raymond James Financial Inc. Purchases New Shares in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Holdings Lowered by LPL Financial LLC - Defense World
Invesco Biotechnology Genome Etf (PBE) 財務データ
Invesco Biotechnology Genome Etf (PBE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.20%
大文字化:
|
ボリューム (24 時間):